Lv64
2410 积分 2022-01-19 加入
Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma
1天前
已完结
Glypican-3-targeted therapy in hepatocellular carcinoma: biological insights and therapeutic strategies
1天前
已完结
Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials
1天前
已完结
Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy
9天前
已完结
Tumor-infiltrating plasma cell profiling after PD-1 blockade reveals tumor-specific antibodies
14天前
已完结
Non-lytic viral immunotherapy induces long-term glioblastoma survival and tumor-specific immunity without eliciting an antiviral response
16天前
已完结
Cystine restriction alleviates T cell exhaustion and enhances CAR-T cell potency
27天前
已完结
Efficient and precise programmable DNA knock-in without double-strand breaks
28天前
已完结
LEF1 and niche factors determine T cell stemness across chronic diseases
1个月前
已完结
Synthetic super-enhancers enable precision viral immunotherapy
1个月前
已完结
皖公网安备34019202002308
